Annual Drug Patent Expirations for XEPI
Xepi is a drug marketed by Ferrer Internacional and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug.
This drug has forty-four patent family members in twenty-five countries.
The generic ingredient in XEPI is ozenoxacin. Two suppliers are listed for this compound. Additional details are available on the ozenoxacin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
